Johnson & Johnson Innovative Medicine company-sponsored congress materials which have been accepted for congress presentation at World Conference on Lung Cancer

FIN-EGFR/CNS: Real World Survival and patient characteristics of Epidermal Growth Factor Receptor (EGFR) mutated Non-Small Cell Lung Cancer (NSCLC) Patients with central nervous system (CNS) Metastases in Finland

CARVYKTI_US-SR-10459

CARVYKTI_US-SR-10545

Test-EL

Submit your medical inquiry

Contact J&J Medical Connect for your medical inquiries


This page was last modified on

Additional contact #{index}

janssenscience

Congress Materials

Payer

Dark Blue

oncology

finegfr-cns-real-world-video

Whitelist Modal

FIN-EGFR/CNS: Real World Survival and patient characteristics of Epidermal Growth Factor Receptor (EGFR) mutated Non-Small Cell Lung Cancer (NSCLC) Patients with central nervous system (CNS) Metastases in Finland

Connect with us

Connect with us

Live video

Waiting for agent...

Ready to join